KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amgen (AMGN) Other Operating Expenses (2016 - 2025)

Amgen (AMGN) has 17 years of Other Operating Expenses data on record, last reported at $3.1 billion in Q4 2025.

  • For Q4 2025, Other Operating Expenses fell 3.81% year-over-year to $3.1 billion; the TTM value through Dec 2025 reached $13.3 billion, up 1.85%, while the annual FY2025 figure was $13.3 billion, 1.85% up from the prior year.
  • Other Operating Expenses reached $3.1 billion in Q4 2025 per AMGN's latest filing, down from $3.4 billion in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $3.8 billion in Q1 2025 and bottomed at $1.6 billion in Q1 2021.
  • Average Other Operating Expenses over 5 years is $2.5 billion, with a median of $2.8 billion recorded in 2023.
  • Peak YoY movement for Other Operating Expenses: surged 99.01% in 2021, then crashed 36.51% in 2022.
  • A 5-year view of Other Operating Expenses shows it stood at $1.8 billion in 2021, then dropped by 3.17% to $1.7 billion in 2022, then soared by 81.96% to $3.1 billion in 2023, then rose by 1.8% to $3.2 billion in 2024, then dropped by 3.81% to $3.1 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Other Operating Expenses were $3.1 billion in Q4 2025, $3.4 billion in Q3 2025, and $3.1 billion in Q2 2025.